ZLZ Peptide
Finnrick has tested 232 samples from ZLZ Peptide across 9 products.
Finnrick Vendor Profile
to
ZLZ Peptide
Tracking 9 products
232 total samples tested
Last test 5 May 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Ipamorelin | 6 | 3 Oct 2025 | 26 Jan 2026 | |||||
| Sermorelin | 4 | 17 Jul 2025 | 20 Feb 2026 | |||||
| GHK-Cu | 14 | 4 Aug 2025 | 5 May 2026 | |||||
| BPC-157 | 10 | 31 Jul 2025 | 9 Mar 2026 | |||||
| Retatrutide | 90 | 20 Jun 2025 | 28 Apr 2026 | |||||
| Semaglutide | 8 | 11 Jun 2025 | 10 Feb 2026 | |||||
| TB-500 | 4 | 9 Oct 2025 | 29 Dec 2025 | |||||
| Tesamorelin | 12 | 4 Aug 2025 | 28 Apr 2026 | |||||
| Tirzepatide | 83 | 20 Jun 2025 | 5 May 2026 | |||||
The ZLZ Peptide samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
4.8
Based on 40 overall satisfaction reports
Ease of Purchase4.1(38)
Payment Methods3.5(38)
Delivery Speed4.6(40)
Packaging Quality4.7(40)
Customer Service4.8(30)
People who submitted test requests to Finnrick gave ZLZ Peptide an average satisfaction rating of 4.8 out of 5 across 40 reports associated with samples received and tested by Finnrick. Customers rated ease of purchase (4.1/5) and payment methods (3.5/5) comparatively lower.
Most recent ZLZ Peptide tests
Samples are tested in commercial labs
232
tests
9
products
Scores
AVGMINMAX
First
11 Jun 2025
Last
5 May 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 5 May 2026 | Tirzepatide | View | 5mg | 5.1mg | +2.0% | 98.80% | 731226T | Clear Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 5 May 2026 | GHK-Cu | View | 50mg | 44mg | -12.0% | 99.80% | 531226G | Clear Label / Silver Crimp / White Cap | Lab E | Public | |
| 28 Apr 2026 | Retatrutide | View | 40mg | 29.8mg | -25.5% | 99.90% | (no batch ID) | No Label / Silver Crimp / Red Cap | Lab E | Public | |
| 28 Apr 2026 | GHK-Cu | View | 100mg | 102.1mg | +2.1% | 99.60% | 03/12/2026 | (no data) | Lab E | Public | |
| 28 Apr 2026 | Tirzepatide | View | 50mg | 49.4mg | -1.2% | 99.90% | 3/05/2026 | (no data) | Lab E | Public | |
| 28 Apr 2026 | Tirzepatide | View | 15mg | 15.5mg | +3.3% | 99.90% | 312226Y | Clear Label / Silver Crimp / Clear Pink Cap | Lab E | Public | |
| 28 Apr 2026 | Tesamorelin | View | 5mg | 5.58mg | +11.6% | 99.90% | 03/12/2026 | (no data) | Lab E | Public | |